Drug
Albutein 20
Albutein 20: highest development phase Phase 3, developed by Grifols. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Grifols
Trials
| Drug | Phase | Indication |
|---|---|---|
| Albutein 20% NCT03451292 | Phase 3 | Decompensated Cirrhosis and Ascites |
Latest
No recent events.
Follow Albutein 20 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.